Spero Therapeutics, Inc. <SPRO.O>: H.C. Wainwright Raises Target Price to $6 From $5
SPRO•Related News
SS&C GlobeOp hedge fund performance index rises 0.83% in August 2026
SSNC•
NextEra, Dominion Energy unveil enhanced Virginia customer benefits package tied to proposed merger
NEE•
Hain Celestial Q4 FY26 net loss narrows to USD 62 million; net sales drop 28% to USD 263 million y/y
HAIN•
Delek US Holdings Inc <DK.N>: Raymond James Raises Target Price to $90 From $72
DK•
Stocks dented by AI warnings; oil jumps again
SPY•